Morphic Holding, Inc. (MORF): Price and Financial Metrics
MORF Price/Volume Stats
| Current price | $56.99 | 52-week high | $57.00 |
| Prev. close | $56.97 | 52-week low | $19.34 |
| Day low | $56.97 | Volume | 1,795,800 |
| Day high | $57.00 | Avg. volume | 1,272,131 |
| 50-day MA | $45.49 | Dividend yield | N/A |
| 200-day MA | $33.75 | Market Cap | 2.85B |
MORF Stock Price Chart Interactive Chart >
Morphic Holding, Inc. (MORF) Company Bio
Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.
MORF Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | 85.03% |
| 1-year | 146.39% |
| 3-year | 11.99% |
| 5-year | 239.63% |
| YTD | 97.33% |
| 2023 | 7.96% |
| 2022 | -43.54% |
| 2021 | 41.22% |
| 2020 | 95.51% |
| 2019 | N/A |
Loading social stream, please wait...